TRIBUTYRIN FORMULATION GUIDE

Tributyrin microcapsule powder: what does the content mean?

How to read a powder specification and turn it into clearer questions for your supplier and formulation team.

The molecule and the commercial powder

Tributyrin is a glycerol ester of butyric acid. A commercial tributyrin microcapsule powder is a formulated ingredient presentation rather than simply another name for the isolated molecule. Its composition includes the encapsulation system as well as the tributyrin.

This distinction matters when comparing quotes. A price per kilogram of powder, a stated tributyrin content and the amount of powder used in a serving are different pieces of information. Record all three separately in a purchasing or formulation spreadsheet.

Read the content on the correct basis

The material provided for Olikong’s portfolio lists 48–52% tributyrin in a microcapsule powder. Before using that figure in a formulation, ask for the current specification, the assay method and the basis on which the result is reported. Where relevant, clarify whether a percentage is stated as received or on another defined basis.

A specification range is not the same as the measured result on a particular batch. Review the lot documentation and understand which value the formulation and quality teams will use in their calculations.

A simple calculation, with clear limits

If a hypothetical powder contains 50% tributyrin by mass, then 500 mg of that powder contains 250 mg of tributyrin. Using the same assumption, a formula requiring 200 mg of tributyrin would contain 400 mg of powder before accounting for the rest of the formula.

These examples explain mass fractions only. They are not serving recommendations. They do not describe the amount released or absorbed in the body, and they do not show equivalence to butyric acid or a butyrate salt. Keep ingredient-content calculations separate from biological or clinical claims.

What does microencapsulation tell you?

Microencapsulation describes a way an ingredient is presented within an encapsulation system. To assess the offered product, request information on its composition, relevant handling properties and supporting stability or release data where available.

A microcapsule illustration cannot establish gastric resistance, a release duration or a particular release location. Those statements need evidence for the actual ingredient system under relevant conditions. Ask what test was used and which material was tested.

Choose a sample test that matches the format

For capsules, tablets or powder blends, define the processing and quality questions you need the sample to answer. Consider the ingredient’s role in your blend, the target fill or tablet weight, sensory requirements, packaging and storage plan. A successful supplier discussion should identify which questions can be answered with existing documents and which require a trial.

Visit the tributyrin microcapsule powder profile to prepare an enquiry for Olikong.

Sources & scope

The 48–52% range is taken from supplied product material. Confirm current commercial documentation before use.

START WITH YOUR REQUIREMENTS

Discuss your ingredient project.

Share your destination market, target format, estimated quantity and the documents your team needs.

Request ingredient information